News

A protein newly found in the naked mole rat may help explain its unique ability to ward off cancer.

Companies have into a definitive merger agreement under which Pfizer will acquire Hospira for $90 a share in cash for a total enterprise value of approximately $17 billion.

Alliance consolidates fluorescence lifetime technology to form a one-stop shop for compound screening.

Using a compact multi-organ chip, and those of three separate microcircuits, researchers can study the regeneration of certain kidney cells.

New blood test will spot bowel cancer at earliest stage, removing the need for ‘unpleasant’ faecal screens.

The Tsinghua Branch of National Center for Protein Sciences Beijing will be a focal point in Asia for research with the first complete cryo-electron microscopy workflow for structural biology.

Grant to fund the on-going research to further elucidate the pharmacological effects of ocriplasmin.

$200,000 grant awarded to develop the next generation of antibacterial cleansers and disinfectants.

Cleave Biosciences has begun a Phase 1 clinical trial to evaluate CB-5083.

Ovasave and Col-Treg regulatory status update in the United States, expected mid-2015.